The serum creatinine concentration is widely interpreted as a measure of the glomerular filtration rate (GFR) and is used as an index of renal function in clinical practice. Glomerular filtration of creatinine, however, is only one of the variables that determines its concentration in serum. Alterations in renal handling and metabolism of creatinine and methodological interferences in its measurement may have a profound impact on the serum concentration of creatinine. We review the fundamental principles of physiology, metabolism, and analytical chemistry that are necessary to correctly interpret the serum creatinine concentration. These principles are then applied to important clinical circumstances, including aging, pregnancy, diabetes mellitus, drug administration, and acute and chronic renal failure. Despite numerous limitations, serum creatinine remains a useful clinical tool, but more accurate measures of renal function are frequently necessary. We will first discuss principles of physiology, metabolism, and analytical chemistry that are necessary for proper understanding of the serum creatinine concen-
The serum creatinine concentration is widely interpreted as a measure of the glomerular filtration rate (GFR) and is used as an index of renal function in clinical practice. Glomerular filtration of creatinine, however, is only one of the variables that determines its concentration in serum. Alterations in renal handling and metabolism of creatinine and methodological interferences in its measurement may have a profound impact on the serum concentration of creatinine. We review the fundamental principles of physiology, metabolism, and analytical chemistry that are necessary to correctly interpret the serum creatinine concentration. These principles are then applied to important clinical circumstances, including aging, pregnancy, diabetes mellitus, drug administration, and acute and chronic renal failure. Despite numerous limitations, serum creatinine remains a useful clinical tool, but more accurate measures of renal function are frequently necessary. The concentration of creatinine in serum is the most widely used and commonly accepted measure of renal function in clinical medicine. The clinical utility of the serum creatinine concentration centers on its relation to the glomerular filtration rate (GFR). Proper use of the serum creatiine value depends critically on insights into the physiology and pathophysiology of glomerular filtration, knowledge of the metabolism and renal handling of creatiine, and methodology of creatinine measurement. It has been our experience, however, that use of serum creatiine as an index of renal function is characterized commonly by misconceptions and misinterpretations.
We believe that this situation reflects, for the most part, incomplete understanding of the theoretical foundation underlying this index, as well as poor dissemination of newly acquired, important knowledge. We wish, therefore, to reexamine the relationship of serum concentrations of creatinine to renal function in light of new physiological and pathophysiological information, recent advances in medical technology, and potential new therapies for progressive renal disease.
We will first discuss principles of physiology, metabolism, and analytical chemistry that are necessary for proper understanding of the serum creatinine concen- Then, we will apply these principles to commonly occurring clinical circumstances.
Division of
We conclude that, despite numerous liinitations, serum creatimne remains a useful clinical tool, but that more accurate measures are frequently necessary for assessment of renal function.
PhysIology and Metabolism

Glomerular Filtration Rate
Each human kidney contains 106 capillary units called glomeruli (1) .The glomeruli produce an ultrailltrate of plasma as a result of pressure-driven filtration across the semipermeable glomerular capillary basement membrane.
For the GFR of a single nephron (SNGFR), this relationship is quantitatively expressed by the following equation:
where Kf = ultrafiltration coefficient (the product of surface area and hydraulic permeability); PTJF = net ultrafiltration pressure, derived from the difference between the mean transcapillary hydrostatic (&') and oncotic (ir) pressures.
Although not obvious from this equation, SNGFR varies directly with the renal plasma flow, because of the relationship between renal plasma flow, SF, and ir.
Whole-kidney GFR, the composite of SNGFR of all functioning glomeruli, is measured classically as the renal clearance of inulin. Renal clearance, as originally defined (2), is based on the axiom that the rate by which a substance is removed from the plasma by the kidney must be equal to the rate of its excretion into the urine. By knowing the urine and plasma concentrations of a substance and the urine flow rate, one can calculate the clearance, which may be conceptualized as the theoretical or virtual volume of plasma from which this substance is completely removed during a particular time period. The renal clearance of substance x (C,) is calculated by using the following equation: C, = UV/P where U is the urinary concentration of substance x, P. is the average plasma or serum concentration of substance x, and V is the urine flow rate. By definition, the renal clearance of a perfect filtration marker, as defined below, is equal to GFR and is independent of its concentration in the blood or of the infusion rate (3). An extensive body of data supports the concept that inulin is a perfect filtration marker, justifying its use as the "gold standard" for the measurement of GFR (4) . Inulin (molecular mass -50O0 Da, molecular radius 130-150 nm) is freely filterable at the glomerulus; not reabsorbed, secreted, or metabolized by the renal tubule; not bound to plasma proteins; nontoxic; and physiologically inert. Because of the necessity for intravenous infusion and the difficult chemical assay required for mum measurement, however, this method has not been used widely in clinical practice and remains largely a research tool. The GFR (measured as inulin clearance) of normal adults under the age of 30 years determined under standardized conditions approximates 130 mL/ mm per 1.73 m2 of body surface area in men and 120 mL/min per 1.73 m2 in women and declines with age thereafter (5, 6). Deviation of the GFR from normal values for age may result from various influences, including diet, postural changes, alterations in renal nervous tone, hormones, prostaglandins, atrial natriuretic peptide, drugs, pregnancy, and renal diseases. Because of such influences, the GFR is best determined under standardized conditions, which include discontinuation of medication, prior fasting, supine posture, sufficient water loading to maintain a urine flow rate >1 mL/min, and complete bladder emptying. Obviously, clinical circumstances make it difficult to adhere to these standards, particularly in acute illness. Moreover, recent and extensive work clearly demonstrates that the decrement in K due to renal disease is accompanied by compensatory increases in P, which may result in a stable GFR despite significant parenchymal injury. Thus, the GFR may be insensitive to the presence of renal disease. Yet, an extensive body of clinical and experimental information suggests that, despite its variability and relative insensitivity to renal disease, the GFR measured as inulin clearance is the best overall index of renal function (3, 4) . Although other filtration markers, including radioisotope-labeled low-Me compounds, have been studied extensively, only a few are used routinely for assessing the GFR in clinical circumstances (7) (8) (9) (10) (11) (12) . The remainder of this discussion will focus on serum creatinine concentration and creatinine clearance as indices of the GFR and on the clinical circumstances in which assessment of the GFR by alternative filtration markers is indicated.
Serum Creatinine and GFR
The use of serum creatinine as a marker of the GFR originated from the work of Rehberg, who in 1926 studied the renal clearance of exogenously administered creatinine (13). Methodological limitations precluded measurement of endogenous serum creatinine and the endogenous creatinine clearance until 1938 (14) . Since then, numerous studies have examined the relationship of serum creatinine and endogenous creatinine clearance to the GFR. Implicit in the utilization of serum creatinine as a marker of the GFR is the assumption that the following two criteria are satisfied: first, that creatinine is a perfect filtration marker; and second, that creatinine metabolism is constant among individuals and over time, with the creatinine production rate being equal to the renal excretion rate. In the theoretical situation where both criteria are satisfied, the serum creatinine is inversely proportional to the GFR, so that each halving of the GFR results in a doubling of the serum creatinine concentration (15) . As discussed below, however, creatinine is not a perfect filtration marker, and creatinine metabolism is not constant over time or among individuals, particularly in disease states. clearance to 1.0, regardless of the plasma creatinine level, thereby providing additional evidence for tubular secretion of creatinine. Despite the description of tubular creatinine secretion more than half a century ago (13) and its recent reemphasis (18), this contribution to creatiine excretion and the resulting overestimation of GFR have largely been ignored. We suspect that one reason for ignoring creatinine secretion might be that knowledge of the precise value for the GFR has previously had little impact on clinical decision making. As discussed later in more detail, an additional reason relates to the fact that serum creatiine concentration determined as the "chromogen creatinine" in the traditional Jaffe reaction is higher than the "true creatinine" measured by more accurate methods; thus, the calculated value for clearance is lower than the true value. Consequently, because of tubular creatinine secretion, the creatiine clearance overestimates the GFR, and because of inclusion of noncreatinine chromogens in the measurement of serum creatinine, the estimated creatinine clearance is less than the true value. The net result is that estimated creatinine clearance deviates little from the GFR in normal individuals. However, because tubular creatiine secretion and the quantity of noncreatinine chromogens in the serum are unrelated phenomena and vary independently in disease, important misrepresentations of the GFR may result. Several reports indicate that in patients with low rates of urine flow, e.g., in decompensated heart disease or uncontrolled diabetes, the ratio of clearances of creatiine and inulin is <1.0, raising the possibility of tubular reabsorption of creatinine (20) (21) (22) (23) (24) .Indeed, observations in normal humans (25) or animals with very low urine flow rates have confirmed this possibility (26, 27) . In addition to renal tubular reabsorption of creatinine, reabsorption of creatiine from the lower urinary tract of the dog also has been demonstrated (27) . Creatinine reabsorption during low rates of urine flow is thought to result from its passive back-diffusion from the lumen to the blood. Thus, when urine flow rate is very low, passive reabsorption of creatinine might result in a lower creatinine clearance and a higher concentration of serum creatinine than what one would expect solely on the basis of the GFR. Based on the clearance ratios observed in these studies, the maximum effect of passive creatinine reabsorption probably amounts tooy a 5-10% decrease in creatinine clearance (20) (21) (22) (23) (24) (25) .
Creatinine as a Filtration Marker
Creatinine clearance as an index of GFR. In summary, creatiine is an imperfect marker of glomerular filtration because it is regularly secreted and at times reabsorbed by the renal tubules. Hence, creatinine clearance provides only a rough guide to the GFR. The complex nature of renal handling of creatinine is augmented by the fact that the degree of tubular secretion or reabsorption of creatinine is variable and unpredictable, especially in the presence of renal disease. Dietary protein deficiency leads to negative nitrogen balance and loss of muscle mass, thereby decreasing creatiine production. Less severe alterations in the diet, however, also may have important effects on the size of the creatine pool and creatinine excretion, which are independent of nitrogen balance and muscle mass. The two components of the diet that directly impact on the size of the creatine pool are protein and creatine. Evidence suggests that reductions in dietary protein mediate small decreases (by 5-15%) in the size of the creatine pool; such decreases appear to reflect reduced availability of the creatine precursors arginine and glycine (44, 56) . Of greater importance, however, is the amount of creatine provided by the diet. Creatine is largely ingested in meat; uncooked lean beef contains -3.5-5 mg of creatine per gram (57, 58) . Crim et al. (59, 60) demonstrated that dietary creatine intake influences the size of the creatine pool and urinary creatinine excretion independent of nitrogen balance and muscle mass: Normal men ingesting a meat-free diet that contained a creatine supplement, who were placed subsequently on a creatine-free diet, had a decrease in the creatine pool and urinary creatinine excretion approximating 13-15%; creatine turnover rates remained unchanged. A similar effect was described by Bleiler and Schedl (Figure 3 ) (56). Other studies have shown that supplementing the diet with up to 1 g of pure creatine increases urinary creatinine excretion by as much as 25% (56, [61] [62] [63] changes in creatinine production. Returning to the example of a 70-kg man with a total creatine pool of 120 g, creatinine production will be 1.92 g per day if the turnover rate is 1.6% per day, but will increase to 2.40 g per day if the turnover rate were to increase to 2.0% per day. There is minimal information on the effects of disease on the creatine turnover rate; therefore, the impact of this factor on creatinine production remains unknown.
The few available studies indicate, however, substantial variation from normal rates under certain clinical circumstances.
For example, in one study, creatine turnover rates in eight children recovering from protein-energy malnutrition ranged from 1.5% to 2.6% per day (49). In another study, one patient with "late onset myopathy" and another patient with amyotrophic lateral sclerosis had relatively normal rates of 1.3% per day, whereas four patients with muscular dystrophy had accelerated rates of creatine turnover of 2. Moreover, changes in the GFR transiently affect creatmine excretion: for example, an increase in the GFR will lead to a transient increase in urinary creatimne excretion; if creatinine production remains constant, the total body creatinine content will decline, resulting in a decrease in serum creatinine concentration and a return to the previous rate of urinary creatinine excretion. A return of the GFR to the previous value would result in a transient decrease in urinary creatinine excretion, even though creatinine production remains constant. With these limitations in mind, we have examined several studies describing altered creatinine excretion in humans.
Trauma or febrile states have been associated with significant increases in the excretion of creatiine (72) (73) (74) (75) ; however, it is uncertain whether the GFR changed in these studies. Prolonged immobilization of normal men maintained in a body cast from the umbilicus to the toes decreased the muscle mass of the lower extremities, yet urinary creatiine excretion did not decrease (76). Although neither investigated nor commented upon by the original authors (76), the stability of creatinine excretion during immobilization suggests an increase in creatine turnover rate, because the creatine pool must have decreased, given the loss of muscle mass. Vigorous exercise may also affect creatinine excretion, but it is not clear whether this effect is due primarily to changes in renal creatinine handling or to changes in creatinine production (77, 78) . Hepatic disease also is associated with a 50% decrease in creatinine excretion per kilogram of total body weight, regardless of the presence or absence of ascites (41, 79) . Whether this finding is due to muscle wasting or, as recently proposed, diminished hepatic creatine synthesis has not been determined.
In summary, creatinine production is readily altered by changes in diet and probably by many different disease states as well. Such influence results mainly from changes in the size of the creatine pool but also from changes in meat intake and possibly from alterations in the fractional turnover of creatine to creati (94, 101, (111) (112) (113) (114) (115) (116) (117) (118) (119) (120) .
The adsorption method, once popular, has given way to other methods because it could not be automated. However, some still consider this a reference method (100) . Of the other alternatives, only the kinetic alkaline picrate and enzymatic methods have application in clinical practice.
Kinetic alkaline picrate method. The kinetic alkaline picrate method takes advantage of the differential rate of color development for noncreatinine chromogens vs that for creatinine, thus allowing a rate-dependent separation of creatinine from interfering substances. This method significantly reduces, but does not eliminate, positive interferences from both categories of noncreatiine chromogens; however, high concentrations of bilirubin still can reduce substantially the measured creatinine concentration (121) . At the time of the most recent survey of creatiine methods by the College of
American
Pathologists in 1985, kinetic alkaline picrate methods were the most widely used in clinical laboratories in the United States (122) . As with other methods measuring "true creatinine," the kinetic alkaline picrate values are -20% lower than those obtained by using the standard Jaffe reaction method. Thus, the reference range for serum creatinine for the normal populations is lower when measured by these newer methods and, correspondingly, the reference range for creatiine clearance is higher. As mentioned before, variation in reference ranges poses a problem in comparing results from clinical or research laboratories that use different methods. ference, thereby reducing the measured creatinine by -15% (123) . Flucytosine may increase the measured concentration of serum creatinine by as much as 60 mg/L (116, 124, 125 ). In fact, Noble et al. (124) even suggested that serum flucytosine could be quantified by the Ektachem technique for creatimne. Urine creatinine can also be determined by the Ektachem method; however, the urine must be pretreated with resin to remove the large amount of ammonia present. The Ektachem creatimne values in serum are comparable with those obtained by using kinetic alkaline picrate methods (114, 122) .
The Creatinine PAP method (Boebringer Mannheim GmbH, Mannheim, FRG) is based on the enzymatic degradation of creatinine to creatine by creatininase, of creatine to sarcosine by creatinase, and of sarcosine to formaldehyde, glycine, and hydrogen peroxide by sarcosine oxidase (Figure 4) (117-120) . Hydrogen peroxide is then quantified by a reaction with 2,4,6-tribromo-3-hydroxybenzoic acid, 4-aminoantipyrine, and peroxidase to yield a chinone (purple) dye. Creatine is also measured in the assay; to adjust the results for this, the sample is also analyzed without creatininase and the amount of hydrogen peroxide derived from creatine is subtracted from the total. Noncreatinine chromogens are not detected; however, bilirubin concentrations of 70-180 mg/L decrease values of creatinine by 1-6 mg/L, and calcium dobesilate, a drug used to reduce capillary permeability in diabetic retinopathy, at therapeutic concentrations may depress the serum creatinine concentration by 2 mg/L (118) . Creatinine values derived by this method are similar to those derived from the kinetic alkaline picrate method but the cost is -10-fold greater (120) . Imprecision of the assays. All commonly used methods, including the kinetic alkaline picrate reaction and the Ektachem method, but apparently not the Creatinine PAP method, are imprecise in the lower range. In one study, the coefficients of variation (CVs) for repeated measurements of aliquots from serum samples within the same run were 25.1%, 7.3%, and 1.9%, respectively, for samples with creatinine concentrations of 4.2, 13.2, and 43.8 mgfL (94) . Indeed, Rosano and
of day-to-day variability in serum creatinine results in an individual. Such a deficiency makes it difficult to interpret changes in serum creatinine within the normal range, which may in fact represent the largest absolute change in renal function. In one study, the CV for repeated measurements of serum creatinine in individuals with a GFR >30 mL/min per 1.73 m2 was 11%; in individuals with a GFR <30 mLfmin per 1.73 m2, it was 6.5% (7) .
The CV for repeated measurements of creatiine clearance exceeds that for serum creatimne. This finding is predictable because day-to-day variability in creatinine clearance includes not only day-to-day biological and analytical variability in serum creatinine, but also biological and analytical variability in urinary creatinine excretion. In various studies, the day-to-day CV for 24-h creatinine clearance in healthy populations ranges from --10% (126) to 17% (127) . Changes in the intake of creatinine and creatine and true changes in the GFR contribute to variability in creatiine excretion; the quantitative effect of these factors has not been studied. Error in 24-h urine collections is another source of variability. In one practice, errors in timing, incomplete collections, spills, and leaks were common; the mean day-to-day CV in patients with normal or slightly impaired renal function was as high as 27% (128) .
The lower CV for day-to-day measurements of serum creatinine than for creatimne clearance indicates that it is easier to detect changes in serum creatimne than in creatinine clearance. Unfortunately, the GFR was not measured in these studies; hence, it is not possible to assess the sensitivity or specificity of changes in serum creatinine or creatinine clearance in detecting changes in the GFR.
Other variations. An additional difficulty in creatimne clearance measurements that may be relevant in both clinical practice and research is the possibility of interconversion of creatimne and creatine in urine during storage. As discussed earlier, the conversion of creatine to creatinine is nonenzymatic and its rate is sensitive to both temperature and pH. The reverse reaction also can occur. At physiological pH and room temperature, <5% of urinary creatine and creatinine are affected by these interconversions. However, at pH 4, which may occur if weak acid is added to prevent bacterial overgrowth during storage, and at temperatures near body temperature, as much as 5% of creatinine per day may be converted to creatine and up to 25% of creatine per day may be converted to creatinine (129) . Under these circumstances, the interconversions may significantly affect the estimation of creatimne excretion and hence of creatinine clearance.
ClInical ApplIcatIons
It is apparent from the foregoing discussion that creatiine excretion, metabolism, or measurement is altered in a significant manner in many clinical situations (Tables 1 and 2 ). We selected six common clinical settings in which there are multiple alterations in the (130, 131) . The cause of these lesions is not known, but it is hypothesized that they are related to generalized arteriosclerosis, the higher blood pressure observed in older populations, and a lifetime of excessive intake of dietary protein (131) (132) (133) .
Renal plasma flow and the GFR normally decrease with aging. Cross-sectional studies in healthy men show that the average decline in the GFR is 10 mL'min per 1.73 m2 per decade after age 30 years (6, 134). In effect, the average GFR declines from -130 to 80 mL/min per 1.73 m2 as the subjects age from 30 to 80 years. Renal plasma flow decreases by a similar proportion so that the filtration fraction (the ratio of GFR to renal plasma flow) remains unchanged (6).
Because of the decline in the GFR, renal creatinine clearance is also decreased in older subjects. Cross- Thus, the normal creatinine clearance decreases from -140 to 100 mL/min per 1.73 m2 from age 30 to 80 years. However, the ratio of creatiine clearance to inulin clearance in the same subjects was highly variable and was not correlated with age. It, therefore, follows that creatinine secretion does not change predictably with age.
Normal aging is also associated with a decline in renal For example, creatinine excretion in a 70-kg man would decline, on average, from -1600 to 1000 mg/day with 'The reader will notice a slight discrepancy between creatinine production calculated by these formulas and that derived from the total creatme pool size and creatine turnover rate. Creatinine production estimated by the latter method is 1920 mg for a 70-kg man (120-g pool x 0.016 daily fractional turnover rate). Creatinine production estimated by equation 5 will yield a similar estimate only at age 4.5 years. This discrepancy is not yet explained but is thought to derive from excess representation of subjects older than 30 years in studies of creatinine excretion, whereas younger subjects are used in determinations of creatine pool size. for the decline in creatiine excretion with aging include decreased creatimne generation attributable to reduced muscle mass or to reduced meat intake. We are aware of no data regarding extrarenal excretion of creatiine as a function of age. The serum concentration of creatinine is relatively normal in older individuals as a result of proportionate reduction in both the clearance and the production of creatinine (139) . In the previous example, an agerelated decline in creatinine clearance from 140 to 100 mL/min per 1.73 m2 is associated with a parallel decline in creatiine excretion (assumed to equal production) from -1600 to 1000 mg/day. Consequent to these two changes, the serum creatinine would be 9 mgIL for 30-year-old and 7 mgIL for 80-year-old people. A normal concentration of serum creatinine in an elderly patient, (142) . This increase is sustained throughout the second trimester.
Simultaneous determination of endogenous creatinine and inulin clearance demonstrates clearance ratios (creatinine/inulin) that slightly exceed 1.0 in the first and early second trimester, but that are approximately equal to or slightly below this in later pregnancy (143, 144) . Possibly, tubular creatiine secretion is decreased in pregnancy, particularly in the latter half (143) (144) (145) . Alternatively, creatinine reabsorption due to the urinary stasis of pregnancy could account for this finding. Neither of these hypotheses has been tested directly.
Increases in the GFR and creatinine clearance are sustained until delivery, depending on the measure- (144, 145 A variety of changes in renal function and creatinine metabolism occur during episodes of diabetic ketoacidosis and nonketotic hyperosmolar coma. Extreme hyperglycemia, osmotic diuresis, and depletion of extracellular fluid volume may cause a decline in GFR and an increase in serum creatimne. The range of values for GFR and serum creatinine is wide, depending on the severity of the illness and the preexisting degree of renal function. Renal creatinine handling has been investigated in four patients with diabetic coma (24) . In one patient, creatinine clearance exceeded inulin clearance, as expected from the effect of creatinine secretion. However, in the other three patients, creatinine clearance was only one-half to two-thirds the value for inulin clearance, suggesting a tubular reabsorption of creatinine. Urine flow rate in these patients varied from -0.1 to 2.0 mL/min. The authors hypothesized that creatinine reabsorption was the result of intense stimulation of tubular reabsorptive processes associated with extracellular volume depletion. Creatine pool size and turnover have not been studied directly, but the urinary excretion of both creatine and creatinine are increased during diabetic ketoacidosis (24, 162) . was observed in one patient with a GFR as low as 36 mL/min per 1.73 m2 (166). The reasons for the discrepancy between the GFR and serum creatiine in diabetic nephropathy are thought to be similar to those described for other forms of progressive renal disease, as discussed below. Tubular secretion of creatinine is known to be enhanced, resulting in maintenance of creatiine clearance at a higher value than the GFR (18) . It is not known whether creatinine generation or extrarenal mechanisms for creatinine metabolism are altered in advanced diabetic nephropathy. However, decreases in muscle mass, either as a result of muscle wasting or extremity amputation, would decrease creatinine production in the same manner as in nondiabetic patients.
There is current widespread interest in studies to retard the progression of diabetic nephropathy (168) . Detection of the beginning of the inexorable decline in renal function that follows the onset of proteinuria will likely require measurements of the GFR. Studies of a small number of patients with nephropathy from type 1 diabetes suggest a slowing in the rate of decline in the GFR by ingestion of a low-protein diet (169, 170) or by inhibition of angiotensin converting enzyme (170a). If these results are confirmed, it will be necessary for clinicians in practice to obtain more accurate and precise estimates of the GFR in patients with type 1 diabetes to assess the indications for and the effect of therapy.
Drug Administration
Safe and rational administration of a drug must include consideration of two important and interrelated phenomena:
whether there is an effect of altered renal function on excretion of the drug and whether the drug affects renal function. Accurate interpretation of the serum creatinine concentration during drug administration also requires an understanding of drug effects on renal handling, metabolism, and measurement of creatinine.
Effect of drugs on serum creatinine concentration. To simplify the approach to drug-induced alterations in the serum creatimne concentration, it is useful to consider the potential effects of drugs on the GFR and creatinine filtration, tubular creatiine secretion, creatiine generation, extrarenal creatinine metabolism, and creatinine measurement.
Some of these alterations have little or no impact on patient care; others are associated with life-threatening complications requiring urgent medical intervention.
Drugs may reduce the GFR and filtration of creatinine by renal parenchymal injury (e.g., nephrotoxic acute tubular necrosis due to gentamicinor methicillin-induced acute interstitial nephritis); alterations in systemic hemodynamics (e.g., diuretic-induced volume depletion); or changes in intrarenal hemodynamics (e.g., indomethacin-induced inhibition of renal prostaglandin synthesis).
Published works describe the approach to such patients (171); the effect of acute renal failure on the serum creatiine concentration is discussed below. It is customary to think of drugs and renal function only in the context of impaired renal function and consequent drug accumulation. However, administration of glucocorticoids increases the GFR acutely in human subjects with normal renal function and this increase persists during chronic administration for 6 weeks (172). The ultimate duration of the increase in GFR associated with chronic glucocorticoid therapy is not known. These changes may lead to more rapid drug elimination and subtherapeutic concentrations of the drug.
The administration of a drug that interferes with tubular creatinine secretion decreases creatinine clearance and increases the serum creatinine to a new stable concentration.
Because tubular secretion of creatinine in moderate renal insufficiency may account for as much as 60% of total creatiine excretion, complete inhibition of secretion could result in more than a doubling of the serum creatimne concentration.
Drugs known to interfere with tubular secretion of creatinine include phloruin (16), cimetidine (173), probenecid (174), trimethoprim (175), and calcitriol (176,177) .
[Interestingly, the inhibition of tubular secretion of creatinine by high doses of cimetidine appears to be so complete that some investigators have proposed to estimate the GFR by measuring creatinine clearance after prior administration of cimetidine (178,179) ].
Drug-induced impairment of tubular creatinine secretion appears to be functional and reversible and is not necessarily an indication for discontinuation of the drug. Clinicians must establish, however, that the increase in serum creatimne does not in fact reflect a decrease in the GFR caused by renal parenchymal injury from the drug or from an unrelated cause.
Although there are no direct measurements of drug effects on creatinine production, the anticonvulsant phenacemide has been reported to increase the serum creatiine content in association with an increase in urinary creatiine excretion in humans, rabbits, and rats (180). Creatinine clearance was only slightly diminished, which suggests that the source of the increase in creatimne was an increase in creatinine generation (180) ; however, the mechanism of this effect has not been established. Chronic glucocorticoid therapy results in decreased muscle mass and decreased urinary creatinine excretion, suggesting that creatinine production may be reduced secondary to the muscle wasting of prolonged glucocorticoid administration (52). There is no information on drug effects on extrarenal creatinine metabolism.
Drug effects on creatinine measurement depend on the analytical method used. Chromogen creatinine measurement may be falsely increased by as much as 28 mg/L after acute intravenous administration of cefoxitin, at the time of the peak concentration of the drug in serum (181). Other cephalosporins known to contribute to the coborimetnc reaction include cephalothin, cefazolin, and cefamandole (102, 103) . As stated above, flucytosine dramatically increases the amount of serum creatiine measured by the creatimne iminohydrolase method (125). The spurious increase of serum creatinine to >50 mg/L because of the presence of flucytosine has led to emergency consultation requests for "acute renal failure" in our institution.
Review of the medication history and remeasurement of serum creatinine by a chromogen-based method frequently produces a dramatic resolution of such "acute renal failure."
Drug prescription in renal insufficiency.
A recent compendium published by the American College of Physicians provides a detailed guide for prescribing drugs in the presence of renal insufficiency (182) . This listing bases all recommendations on the value for GFR and does not use serum creatinine. The clinician must therefore estimate the GFR before prescribing many commonly used drugs, including aminoglycoside antibiotics, acetaminophen, digoxin, cimetidine, and clofibrate (182). However, within the broad ranges of GFR that are used as a guide (>50, 10-50, and <10 inL/min), it is usually adequate to measure creatinine clearance or estimate it from the serum concentration and one of the formulas referred to earlier.
Acute Renal Failure
Acute renal failure is defined as a rapid deterioration in renal function, resulting in the accumulation of nitrogenous waste products, including creatinine. The mechanism of reduction in GFR in acute renal failure is dependent on the nature of the primary insult and is still the subject of active investigation.
Renal parenchymal iijury, most commonly acute tubular necrosis (ATN), may result from renal ischemia or from exposure to nephrotoxins (171). The primary pathophysiological features of ATN include reduction in renal blood flow, reduction in Kf, altered epithelial cell polarity, tubular obstruction, and filtrate backleak through damaged tubules; depending on the type of ATN, a combination of defects might account for the deterioration in renal function (18.3) .
Reduced creatinine clearance in acute renal failure may result from either impaired creatinine filtration as a result of decreased GFR or "reabsorption" of filtered creatinine as a result of backleak. The rate of increase and the final concentration of serum creatinine depend on many factors, including the severity and time course of resolution of renal irjury, rate of generation of creatmine, volume of distribution of creatinine, and extrarenal creatinine elimination. In principle, if the renal function stabilizes, the serum creatinine concentration will reach a plateau at a value where renal creatinine excretion equals the difference between production and extrarenal elimination of creatimne (15) . When renal function then rises toward normal values, the serum creatinine concentration will start to fall, but only when renal creatinine excretion exceeds the difference between creatiine production and extrarenal elimination. However, because of numerous alterations in acute renal failure, neither the serum creatinine concentration nor its rate of increase are useful in estimating the degree of renal function.
First, the GFR may fall to a value so low that dialysis is necessary before the steady-state increased concentration of serum creatinine is reached. For example, a state of anuria will initially be associated with a creatmine concentration that is only slightly above baseline, despite a GFR that is effectively equal to zero. Only after sufficient time has elapsed will the serum creatinine increase to a value usually associated with severe renal failure. In the absence of intervention by dialysis, serum creatinine will rise relentlessly.
Second, the GFR is not constant during acute renal failure. In one study, Moran and Myers (184) demonstrated that a decrease in the rate of increase of serum creatinine in acute renal failure is actually due to an increasing GFR rather than to a decrease in the rate of decrease of GFR. Thus, serum creatinine may continue to increase in the early phase of recovery from acute renal failure (184) . Third, a large increase in total body water, as commonly occurs after cardiac surgery, increases the volume in which creatinine is distributed and therefore may blunt or even eliminate the increase in the serum creatinine concentration from acute renal failure (184) . For a given decrement in GFR, the rate of rise is inversely correlated with the increase in total body water ( Figure 6 ).
There Acute renal failure per se does not present any particular problems to measurement of creatinine. Nonetheless, one must recognize that many factors affecting creatinine measurement may be present in the setting of acute renal failure and must be carefully evaluated for possible interference.
As in chronic renal failure, the amount of chromogeic substances in blood is increased in acute renal failure, although the specific contribution to creatiine measurement has not been studied. Administration of certain drugs may affect the Jaff#{234} method, as noted above.
Chronic Progressive Renal Disease
The hallmark of most chronic renal diseases is a progressive decline in renal function, eventually culminating in renal failure. In many experimental models of parenchymal renal disease, it is well established that the cause of the reduced GFR is reduced K1, caused by a decrease in either glomerular capillary surface area or hydraulic permeability (132). Single-nephron glomerular capillary blood flow and pressure are increased; as a result, Pur is above normal (see equation 1). The net effect of these alterations is that the reduction in GFR is proportionately less than the decline in K1. (188) concluded that, just as in experimental animals, the decline in GFR in patients with chronic glomerular diseases is due to a decrease in K1 and that P is likely increased.
Numerous clinical trials have been undertaken to assess whether the progression of renal disease in humans can be delayed by the above-mentioned interventions.
Some (189) (190) (191) , but not all (192), controlled trials in nondiabetic subjects with advanced renal disease suggest a beneficial effect of low-protein diets, and a multicenter trial of low-protein diets in patients with only mild to moderate renal insufficiency is ongoing in the United States (193, 194) . A recent report also suggests a beneficial effect of inhibition of angiotensin converting enzyme in humans with nondiabetic renal disease (194a).
Filtration of creatiine is reduced as a consequence of a diminished GFR in chronic renal disease. However, as the GFR falls, the ratio of creatimne to inulin clearance increases because of an increased tubular secretion of creatiine.
The increase in the creatiine/inulin clearance ratio at a low GFR has been studied primarily in cross-sectional studies, but some information is now available from serial follow-up of individual patients. However, there is little information on the type of renal disease. In cross-sectional studies, the ratio of creatinine clearance to inulin clearance increases progressively to values as high as 2.5 at very low values for GFR (14, 18, (20) (21) (22) (195) (196) (197) (198) (199) (200) (201) (202) (203) (204) (205) (206) (207) (208) (209) (210) (211) (212) (213) (214) . The absolute difference between creatinine clearance and inulin clearance (creatinine clearance due to tubular secretion), however, appears greatest at GFRs from 40 to 80 mL/min and decreases at lower GFRs (18,199,201) ( Table 3 ). The increase in the ratio for creatinine/inulin clearance at lower GFRa appears to be due largely to a declining GFR rather than to increasing clearance of creatinine due to tubular secretion. In progressive renal disease, the clearance of creatinine due to tubular secretion tends to decrease, on Other studies have shown that because of the variability in creatinine secretion among individuals, it is not possible to predict changes in GFR from changes in creatiine clearance (215, 217 Differences among patients in values for creatinine production would result in different values for the rate of decline in reciprocal serum creatinine, even if the rate of decline in creatinine clearance is the same. Similarly, in an individual patient, a change in the value for creatimne production would result in a change in the rate of decline in reciprocal serum creatinine, even if the rate of decline in creatinine clearance is unchanged. Differences or changes in extrarenal elimination of creatinine would further alter the relationship between the rates of decline in reciprocal serum creatiine and creatinine clearance. On the basis of these considerations, we suggest that the rate of decline in reciprocal serum creatimne may not reflect accurately the rate of decline in the GFR.
Several studies have examined the correlation between rates of decline in reciprocal serum creatinine and GFR (166, 194, 225, 226) . Despite strong correlations between the value for reciprocal serum creatinine and GFR, correlations between the rates of change were relatively weak. In one study, in which the mean rate of decline in GFR was only -'0.35 mLfmin per 1.73 m2 per month, and the mean duration of follow-up was only -1 year, the correlations improved with increasing duration of follow-up, as did the precision of the individual estimates of the rates of decline in both GFR and reciprocal serum creatiine (227). These data suggest that one reason for the weak correlations is the imprecision in estimating the rate of decline in renal function when the rate is slow and the duration of follow-up is short, presumably because the true change in the extent of renal function is small in relation to the errors inherent in its measurement. Findings were similar regarding the relationship between the rates of decline in creatinine clearance and the GFR (227).
We have investigated the constancy in the rate of decline in reciprocal serum creatinine. Using a method of linear-regression analysis to determine so-called breakpoints (228), we observed spontaneous and significant changes in slope in 30-50% of the patients from our practice and from previously published reports, in which the rate of decline appeared constant by leastsquares linear-regression analysis (r 0.85) (229). The second slope was less steep in 60% of these patients, suggesting that the rate of decline actually slows over time, rather than remaining constant. Slope changes occurred over a range of serum creatiine values from 10 to 150 mgfL, with a mean of 53 mg/L. The magnitude of the change also was variable, with a mean of 0.0007 11mg per month, which is comparable with the change attributed to therapeutic interventions, and resulted in errors in the prediction of the interval until the onset of renal failure. From these data, we concluded that it was inappropriate to extrapolate the regression line relating reciprocal serum creatinine (or any other measure of renal function) vs. time beyond the interval over which the data were collected. Clinical studies should not use patients as their own controls to predict the interval until the onset of uremia or to assess the effectiveness of a therapeutic intervention. Instead, it is necessary to use a concurrent control group. if future studies were to demonstrate that the rate of decline in reciprocal serum creatinine is indeed closely correlated with the rate of decline in GFR, deterioration in renal structure, or the interval until the onset of uremia, then the rate of decline in reciprocal serum creatiine would be a valid, although indirect, measure of the rate of progression. Thus far, its validity has not been established.
Until such validation is produced, we believe it is not appropriate to use only the rate of decline in reciprocal serum creatinine in studies on the progression of chronic renal diseases. Indeed, the conclusions of studies based only on use of this technique must be questioned.
Given the current state of knowledge, we advocate measuring the rate of progression of renal disease in clinical investigation protocols by carrying out serial measurements of GFR. On the other hand, in clinical practice, it has not been considered necessary to know precisely the GFR value or the rate of progression of chronic renal disease. We believe, however, that such thinking will be at variance 
